Treatment of acute cutaneous leishmaniasis with intralesional injection of meglumine antimoniate: Comparison of conventional technique with mesotherapy gun

International Journal of Dermatology

Volumn 49, Issue 9, 2010, Pages 1034-1037

  Kashani, Mansour Nassiri ^a   Sadr, Bardia ^a   Nilforoushzadeh, Mohammad Ali ^a   Arasteh, Mahfar ^b   Babakoohi, Shahab ^a   Firooz, Alireza ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

MEGLUMINE ANTIMONATE;

ACUTE DISEASE; ADULT; ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICE; DISEASE SEVERITY; DRUG EFFICACY; DRUG USE; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MESOTHERAPY; MESOTHERAPY GUN; MINIMALLY INVASIVE PROCEDURE; OUTCOME ASSESSMENT; SKIN LEISHMANIASIS; SYRINGE; TREATMENT DURATION; VISUAL ANALOG SCALE;

ACUTE DISEASE; ADOLESCENT; ADULT; CHILD; FEMALE; HUMANS; INJECTIONS, INTRALESIONAL; LEISHMANIASIS, CUTANEOUS; MALE; MEGLUMINE; MESOTHERAPY; ORGANOMETALLIC COMPOUNDS; PAIN; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77956166147     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2010.04523.x     Document Type: Article

References (14)

1. Dowlati Y. Cutaneous leishmaniasis: clinical aspects. Clin Dermatol 1996, 14:425-431.
2. Desjeux P. Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis 2004, 27:305-318.
3. Yebenes M, Cruz I, Canavate C. Nodular lymphangitic subcutaneous dissemination after intralesional treatment for localized cutaneous leishmaniasis. Clin Exp Dermatol 2008, 33:142-144.
4. Dowlati Y. Treatment of cutaneous leishmaniasis (Old World). Clin Dermatol 1996, 14:513-518.
5. Asilian A, Davami M. Comparison between the efficacy of photodynamic therapy and topical paromomycin in the treatment of Old World cutaneous leishmaniasis: a placebo controlled, randomized clinical trial. Clin Exp Dermatol 2006, 31:634-637.
6. Khatami A, Firooz A, Gorouhi F, Dowlati Y. Systematic review of New World cutaneous leishmaniasis: several points. Int J Dermatol 2009, 48:201.
7. Firooz A, Khatami A, Khamesipour A. Intralesional injection of 2% zinc sulfate solution in the treatment of acute old world cutaneous leishmaniasis: a randomized, double-blind, controlled clinical trial. J Drugs Dermatol 2005, 4:73-79.
8. Zerehsaz F, Salmanpour R, Handjani F. A double-blind randomized clinical trial of a topical herbal extract (Z-HE) vs. systemic meglumine antimoniate for the treatment of cutaneous leishmaniasis in Iran. Int J Dermatol 1999, 38:610-612.
9. Murray HW, Berman JD, Davies CR, Saravia NG. Advances in leishmaniasis. Lancet 2005, 366:1561-1577.
10. Amin SP, Phelps RG, Goldberg DJ. Mesotherapy for facial skin rejuvenation: a clinical, histologic, and electron microscopic evaluation. Dermatol Surg 2006, 32:1467-1472.
11. Rohrich RJ, Janis EJ, Reisman NR. Use of off-label and non-approved drugs and devices in plastic surgery. Plast Reconstr Surg 2003, 112:241-243.
12. Hexsel D, Serra M, Mazzuco R. Phosphatidylcholine in the treatment of localized fat. J Drugs Dermatol 2003, 2:511-518.
13. Salmanpour R, Handjani F, Nouhpisheh MK. Comparative study of the efficacy of oral ketoconazole with intra-lesional meglumine antimoniate (Glucantime) for the treatment of cutaneous leishmaniasis. J Dermatolog Treat. 2001, 12:159-162.
14. Rohrich RJ. Mesotherapy: what is it? Does it work? Plast Reconstr Surg 2005, 115:1425.